These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20528966)

  • 21. Cutaneous carcinosarcoma: adnexal vs. epidermal types define high- and low-risk tumors. Results of a meta-analysis.
    Tran TA; Muller S; Chaudahri PJ; Carlson JA
    J Cutan Pathol; 2005 Jan; 32(1):2-11. PubMed ID: 15660649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maspin expression in normal skin and usual cutaneous carcinomas.
    Reis-Filho JS; Torio B; Albergaria A; Schmitt FC
    Virchows Arch; 2002 Dec; 441(6):551-8. PubMed ID: 12461611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Necrotizing sialometaplasia versus invasive carcinoma of the head and neck: the use of myoepithelial markers and keratin subtypes as an adjunct to diagnosis.
    Rizkalla H; Toner M
    Histopathology; 2007 Aug; 51(2):184-9. PubMed ID: 17650214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p63 immunostaining in destained bronchoscopic cytological specimens.
    Shtilbans V; Szporn AH; Wu M; Burstein DE
    Diagn Cytopathol; 2005 Apr; 32(4):198-203. PubMed ID: 15754365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
    McCluggage WG; Kennedy K; Busam KJ
    Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Squamous cell carcinoma with clear cells: how often is there evidence of tricholemmal differentiation?
    Dalton SR; LeBoit PE
    Am J Dermatopathol; 2008 Aug; 30(4):333-9. PubMed ID: 18645304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of p63 as an effective immunomarker in the diagnosis of pulmonary squamous cell carcinomas on de-stained bronchial lavage cytological smears.
    Uke M; Rekhi B; Ajit D; Jambhekar NA
    Cytopathology; 2010 Feb; 21(1):56-63. PubMed ID: 19744186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous adnexal tumor with an unusual presentation--discussion of a potential diagnostic pitfall.
    Cangelosi JJ; Nash JW; Prieto VG; Ivan D
    Am J Dermatopathol; 2009 May; 31(3):278-81. PubMed ID: 19384070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms.
    Wallace ML; Longacre TA; Smoller BR
    Mod Pathol; 1995 Dec; 8(9):897-901. PubMed ID: 8751328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the peripheral benzodiazepine receptor is decreased in skin cancers in comparison with normal skin.
    Morgan J; Oseroff AR; Cheney RT
    Br J Dermatol; 2004 Oct; 151(4):846-56. PubMed ID: 15491426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck.
    Sauter ER; Nesbit M; Watson JC; Klein-Szanto A; Litwin S; Herlyn M
    Clin Cancer Res; 1999 Apr; 5(4):775-82. PubMed ID: 10213212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of class II beta-tubulin in non-melanoma cutaneous tumors.
    Roh JY; Kee SH; Choi JW; Lee JH; Lee JH; Lee ES; Kim YS
    J Cutan Pathol; 2007 Feb; 34(2):166-73. PubMed ID: 17244029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
    Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eccrine porocarcinoma of the head: an important differential diagnosis in the elderly patient.
    Gerber PA; Schulte KW; Ruzicka T; Bruch-Gerharz D
    Dermatology; 2008; 216(3):229-33. PubMed ID: 18182815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of cytokeratin 7 predicts survival in stage I/IIA/IIB squamous cell carcinoma of the esophagus.
    Yamada A; Sasaki H; Aoyagi K; Sano M; Fujii S; Daiko H; Nishimura M; Yoshida T; Chiba T; Ochiai A
    Oncol Rep; 2008 Nov; 20(5):1021-7. PubMed ID: 18949396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The nuclear factor kappa B p50 subunit and cortactin as markers to distinguish between keratoacanthoma and well-differentiated squamous cell carcinoma.
    Fujii M; Honma M; Takahashi H; Ishida-Yamamoto A; Iizuka H
    Clin Exp Dermatol; 2011 Oct; 36(7):788-92. PubMed ID: 21883393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expression of p63 in actinic keratoses, seborrheic keratosis, and cutaneous squamous cell carcinomas.
    Wrone DA; Yoo S; Chipps LK; Moy RL
    Dermatol Surg; 2004 Oct; 30(10):1299-302. PubMed ID: 15458526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative examination of androgen receptor reactivity for differential diagnosis of sebaceous carcinoma from squamous cell and basal cell carcinoma.
    Asadi-Amoli F; Khoshnevis F; Haeri H; Jahanzad I; Pazira R; Shahsiah R
    Am J Clin Pathol; 2010 Jul; 134(1):22-6. PubMed ID: 20551262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of insulin-like growth factor-I receptor in primary cutaneous carcinomas.
    Keehn CA; Saeed S; Bickle K; Khalil FK; Morgan MB
    J Cutan Pathol; 2004 May; 31(5):368-72. PubMed ID: 15059221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.